Detalhe da pesquisa
1.
A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
Cell
; 187(9): 2269-2287.e16, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608703
2.
Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
Haematologica
; 108(2): 367-381, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073513
3.
TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Leukemia
; 37(10): 1969-1981, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591943
4.
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma.
Nat Commun
; 13(1): 2420, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504924
5.
Correction to: TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Leukemia
; 38(3): 681-682, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272992